12:00 AM
May 24, 2010
 |  BC Week In Review  |  Company News  |  Deals

Nepentes S.A., sanofi-aventis deal

sanofi-aventis will acquire OTC dermatology company Nepentes in a deal that values Nepentes at PLN419.9 million ($129.6 million). Majority shareholders owning 63% of the company have agreed to...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >